Opendata, web and dolomites

GET-UP BAT

GPCR Exploitation To Unlock the Power of Brown/Beige Adipose Tissue

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GET-UP BAT project word cloud

Explore the words cloud of the GET-UP BAT project. It provides you a very rough idea of what is the project "GET-UP BAT" about.

largely    options    extend    sensitivity    initial    hundreds    discovery    ipr    head    life    millions    beta    vivo    treatment    combined    linked    uncovering    adrenergic    harness    compounds    treating    holds    benefit    metabolic    observing    screen    glucose    diabetes    ligand    maximize    disease    activation    patentable    gpcr    acrobat    expectancy    societal    adipose    lived    strengthen    poised    obese    validated    burning    strategy    scope    suffer    lowered    desperately    peptide    strategies    diseases    quality    calorie    consumption    unfortunately    ideally    cardiovascular    economic    consuming    insulin    beige    seek    team    vitro    class    longer    erc    platforms    enormous    mice    administration    consequently    receptors    ip    worldwide    alternatives    poc    performed    cells    obesity    experts    treat    hindered    brown    oxygen    functions    assembled    found    pharmacology    diminish    attempts    protein    grant    adverse    tangible    bat    gcprs    commercial    therapeutic    bodyweight    starting    analogues    critical    combination    tissue    people    coupled    innovation    position   

Project "GET-UP BAT" data sheet

The following table provides information about the project.

Coordinator
KOBENHAVNS UNIVERSITET 

Organization address
address: NORREGADE 10
city: KOBENHAVN
postcode: 1165
website: www.ku.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 149˙986 €
 EC max contribution 149˙986 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) coordinator 149˙986.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Hundreds of millions of people suffer from obesity and diabetes worldwide. These diseases diminish both life quality and expectancy and new treatment strategies are desperately needed. One possible approach is to target the calorie-burning and glucose-consuming functions of brown and beige adipose tissue (B/BAT). Previous attempts to harness the therapeutic potential of B/BAT have largely focused on the β-adrenergic class of G protein-coupled receptors (GCPRs). Unfortunately, these methods are hindered by adverse cardiovascular side effects linked to adrenergic activation. Therefore, uncovering non-adrenergic alternatives to exploit B/BAT for treating metabolic disease holds the potential for enormous societal and economic benefit.

Here, we propose the activation of one such non-adrenergic GPCR on B/BAT as a means to treat obesity and diabetes. We identified this GPCR from a screen of B/BAT receptors performed in my ERC Starting Grant project, aCROBAT. We found that treating brown adipose cells with the peptide ligand for this GPCR increased oxygen consumption. We recognized the therapeutic potential after observing that ligand administration in vivo lowered bodyweight and improved insulin sensitivity in obese mice. However, the resources required to develop this discovery into a tangible innovation extend beyond the scope of aCROBAT.

Consequently, I’m applying for an ERC PoC grant for critical support to take the initial steps to commercial application. Specifically, we seek to strengthen our IP position by developing patentable, longer-lived analogues of the ligand. Importantly, we will test these lead compounds head-to-head and in combination with current treatment options. We have assembled a team of experts to address key aspects from peptide design and pharmacology to IPR strategy and commercial development. Combined with our validated in vitro and in vivo testing platforms, we are ideally poised to maximize innovation potential.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GET-UP BAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GET-UP BAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DDREAMM (2020)

Dna Damage REsponse: Actionabilities, Maps and Mechanisms

Read More  

Growth regulation (2019)

The wide-spread bacterial toxin delivery systems and their role in multicellularity

Read More  

FatVirtualBiopsy (2020)

MRI toolkit for in vivo fat virtual biopsy

Read More